BOLD - Audentes Therapeutics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2019)Next Qtr. (Jun 2019)Current Year (2019)Next Year (2020)
No. of Analysts14141413
Avg. Estimate-0.89-0.92-3.76-3.46
Low Estimate-1.03-1.09-4.46-4.21
High Estimate-0.82-0.82-3.29-1.09
Year Ago EPS-0.74-0.85-3.4-3.76
Revenue EstimateCurrent Qtr. (Mar 2019)Next Qtr. (Jun 2019)Current Year (2019)Next Year (2020)
No. of Analysts11111312
Avg. EstimateN/AN/AN/A10.65M
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/A117M
Year Ago SalesN/AN/AN/AN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History3/30/20186/29/20189/29/201812/30/2018
EPS Est.-0.8-0.78-0.88-0.91
EPS Actual-0.74-0.85-0.97-0.84
Difference0.06-0.07-0.090.07
Surprise %7.50%-9.00%-10.20%7.70%
EPS TrendCurrent Qtr. (Mar 2019)Next Qtr. (Jun 2019)Current Year (2019)Next Year (2020)
Current Estimate-0.89-0.92-3.76-3.46
7 Days Ago-0.89-0.92-3.76-3.49
30 Days Ago-0.89-0.92-3.76-3.47
60 Days Ago-0.95-0.97-3.92-2.87
90 Days Ago-0.95-0.97-3.92-2.87
EPS RevisionsCurrent Qtr. (Mar 2019)Next Qtr. (Jun 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/A1
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 Days111N/A
Growth EstimatesBOLDIndustrySectorS&P 500
Current Qtr.-20.30%N/AN/A-0.02
Next Qtr.-8.20%N/AN/A0.04
Current Year-10.60%N/AN/A0.05
Next Year8.00%N/AN/A0.11
Next 5 Years (per annum)17.40%N/AN/A0.10
Past 5 Years (per annum)N/AN/AN/AN/A